99 related articles for article (PubMed ID: 17442906)
1. Targeted therapy for inherited GPI deficiency.
Almeida AM; Murakami Y; Baker A; Maeda Y; Roberts IA; Kinoshita T; Layton DM; Karadimitris A
N Engl J Med; 2007 Apr; 356(16):1641-7. PubMed ID: 17442906
[TBL] [Abstract][Full Text] [Related]
2. Inherited GPI deficiency: a disorder of histone hypoacetylation.
Georgiou E; Layton M; Karadimitris A
Birth Defects Res C Embryo Today; 2009 Dec; 87(4):327-34. PubMed ID: 19960552
[TBL] [Abstract][Full Text] [Related]
3. Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency.
Almeida AM; Murakami Y; Layton DM; Hillmen P; Sellick GS; Maeda Y; Richards S; Patterson S; Kotsianidis I; Mollica L; Crawford DH; Baker A; Ferguson M; Roberts I; Houlston R; Kinoshita T; Karadimitris A
Nat Med; 2006 Jul; 12(7):846-51. PubMed ID: 16767100
[TBL] [Abstract][Full Text] [Related]
4. Cell-type-specific transcriptional regulation of PIGM underpins the divergent hematologic phenotype in inherited GPl deficiency.
Costa JR; Caputo VS; Makarona K; Layton DM; Roberts IA; Almeida AM; Karadimitris A
Blood; 2014 Nov; 124(20):3151-4. PubMed ID: 25293775
[TBL] [Abstract][Full Text] [Related]
5. Cerebral and portal vein thrombosis, macrocephaly and atypical absence seizures in Glycosylphosphatidyl inositol deficiency due to a PIGM promoter mutation.
Pode-Shakked B; Heimer G; Vilboux T; Marek-Yagel D; Ben-Zeev B; Davids M; Ferreira CR; Philosoph AM; Veber A; Pode-Shakked N; Kenet G; Soudack M; Hoffmann C; Vernitsky H; Safaniev M; Lodzki M; Lahad A; Shouval DS; Levinkopf D; Weiss B; Barg AA; Daka A; Amariglio N; Malicdan MCV; Gahl WA; Anikster Y
Mol Genet Metab; 2019; 128(1-2):151-161. PubMed ID: 31445883
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors upregulate p57Kip2 level by enhancing its expression through Sp1 transcription factor.
Cucciolla V; Borriello A; Criscuolo M; Sinisi AA; Bencivenga D; Tramontano A; Scudieri AC; Oliva A; Zappia V; Della Ragione F
Carcinogenesis; 2008 Mar; 29(3):560-7. PubMed ID: 18204075
[TBL] [Abstract][Full Text] [Related]
7. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells.
Kim YH; Park JW; Lee JY; Kwon TK
Carcinogenesis; 2004 Oct; 25(10):1813-20. PubMed ID: 15142888
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites.
Sowa Y; Orita T; Minamikawa S; Nakano K; Mizuno T; Nomura H; Sakai T
Biochem Biophys Res Commun; 1997 Dec; 241(1):142-50. PubMed ID: 9405248
[TBL] [Abstract][Full Text] [Related]
9. Inherited glycosylphosphatidyl inositol deficiency: a treatable CDG.
Almeida A; Layton M; Karadimitris A
Biochim Biophys Acta; 2009 Sep; 1792(9):874-80. PubMed ID: 19168132
[TBL] [Abstract][Full Text] [Related]
10. MMP28 gene expression is regulated by Sp1 transcription factor acetylation.
Swingler TE; Kevorkian L; Culley KL; Illman SA; Young DA; Parker AE; Lohi J; Clark IM
Biochem J; 2010 Apr; 427(3):391-400. PubMed ID: 20144149
[TBL] [Abstract][Full Text] [Related]
11. Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.
Xiao H; Hasegawa T; Isobe K
J Cell Biochem; 1999 Jun; 73(3):291-302. PubMed ID: 10321829
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter.
Yokota T; Matsuzaki Y; Miyazawa K; Zindy F; Roussel MF; Sakai T
Oncogene; 2004 Jul; 23(31):5340-9. PubMed ID: 15107822
[TBL] [Abstract][Full Text] [Related]
14. Sodium butyrate activates erythroid-specific 5-aminolevulinate synthase gene through Sp1 elements at its promoter.
Han L; Zhong Y; Huang B; Han L; Pan L; Xu X; Wang X; Huang B; Lu J
Blood Cells Mol Dis; 2008; 41(2):148-53. PubMed ID: 18555711
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitor apicidin induces cyclin E expression through Sp1 sites.
Kim S; Kang JK; Kim YK; Seo DW; Ahn SH; Lee JC; Lee CH; You JS; Cho EJ; Lee HW; Han JW
Biochem Biophys Res Commun; 2006 Apr; 342(4):1168-73. PubMed ID: 16516150
[TBL] [Abstract][Full Text] [Related]
16. The histone deacetylase inhibitor trichostatin A derepresses the telomerase reverse transcriptase (hTERT) gene in human cells.
Hou M; Wang X; Popov N; Zhang A; Zhao X; Zhou R; Zetterberg A; Björkholm M; Henriksson M; Gruber A; Xu D
Exp Cell Res; 2002 Mar; 274(1):25-34. PubMed ID: 11855854
[TBL] [Abstract][Full Text] [Related]
17. 1,25-dihydroxyvitamin D3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells.
Huang YC; Hung WC
J Cell Physiol; 2006 Nov; 209(2):363-9. PubMed ID: 16883603
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor accessibility and histone acetylation of the progesterone receptor gene differs between parental MCF-7 cells and a subline that has lost progesterone receptor expression.
Xu X; Murdoch FE; Curran EM; Welshons WV; Fritsch MK
Gene; 2004 Mar; 328():143-51. PubMed ID: 15019994
[TBL] [Abstract][Full Text] [Related]
19. Effects of histone deacetylase inhibitors on the Ah receptor gene promoter.
Garrison PM; Rogers JM; Brackney WR; Denison MS
Arch Biochem Biophys; 2000 Feb; 374(2):161-71. PubMed ID: 10666294
[TBL] [Abstract][Full Text] [Related]
20. [Antidepressive effect of sodium butyrate and its effect on gene expression in rat hippocampus].
Yamawaki Y; Fuchikami M; Morinobu S; Segawa M; Mataumoto T; Yamawaki N
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Apr; 31(2):81-3. PubMed ID: 21870365
[No Abstract] [Full Text] [Related]
[Next] [New Search]
